https://www.bullsnbears.com.au/post/radiopharm-secures-us-approval-for-second-cancer-treatment
Radiopharm Theranostics secures US approval for second cancer treatment
Apr 17, 2024 - A pancreatic cancer treatment developed by ASX-listed Radiopharm Theranostics has been granted orphan drug designation by the United States Food and Drug...
radiopharm theranosticscancer treatmentusapprovalsecond
https://lifestyle.kotaradio.com/story/175664/radiopharm-theranostics-presents-initial-findings-from-phase-1-first-in-human-heat-clinical-trial-for-177lu-rad202-in-her2-solid-tumors-at-american-association-for-cancer-research-2026/
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial...
radiopharm theranosticsclinical trialpresentsinitialfindings
https://upstox.com/us-stocks/radx-share-price/
Radiopharm Theranostics Limited American Depositary Shares Share Price Today - Live NASDAQ: RADX...
Radiopharm Theranostics Limited American Depositary Shares share price live today - Get the stock price of RADX along with the chart, history, and other vital...
radiopharm theranosticsshare pricetoday livelimitedamerican
https://www.bioworld.com/articles/722615-radiopharm-theranostics-cleared-to-advance-rv-01-into-clinic?v=preview
Radiopharm Theranostics cleared to advance RV-01 into clinic | BioWorld
Radiopharm Theranostics Ltd. announced that the U.S. FDA has cleared the IND application for betabart (RV-01), its Lu177-B7H3 monoclonal antibody designed with...
radiopharm theranosticsclearedadvancervclinic
https://pharmadevicenews.com/radiopharm-theranostics-builds-clinical-momentum-with-rad-101-data-that-could-influence-neuro-oncology-workflows/
Radiopharm Theranostics builds clinical momentum with RAD 101 data that could influence...
Mar 25, 2026 - Radiopharm Theranostics reports strong RAD 101 interim data in brain metastases imaging. Read expert analysis on clinical impact and regulatory outlook.
radiopharm theranosticsbuildsclinicalmomentumdata
https://stockanalysis.com/quote/asx/RAD/company/
Radiopharm Theranostics (ASX:RAD) Company Profile & Description
Company profile for Radiopharm Theranostics Limited (ASX:RAD) with a description, list of executives, contact details and other key facts.
radiopharm theranosticscompany profileasxdescription
https://www.nasdaq.com/market-activity/stocks/radx
Radiopharm Theranostics Limited American Depositary Shares (RADX) Stock Price, Quote, News &...
Discover real-time Radiopharm Theranostics Limited American Depositary Shares (RADX) stock prices, quotes, historical data, news, and Insights for informed...
radiopharm theranosticsstock pricelimitedamericandepositary
https://www.sahmcapital.com/news/content/radiopharm-theranostics-announces-that-new-data-from-the-ongoing-phase-01-heat-trial-evaluating-177lu-rad202-a-first-in-class-her2-targeted-radiopharmaceutical-therapy-will-be-presented-as-a-poster-at-the-american-association-for-canc-2026-04-20
Radiopharm Theranostics Announces That New Data From The Ongoing Phase 0/1 Heat Trial Evaluating...
Key Findings from the AACR Abstract and PosterMeaningful tumor uptake of 177Lu-RAD202 was observed at the initial and lowest dose level of 30 mCi, particularly...
radiopharm theranosticsnew dataannouncesongoingphase